Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Tacrolimus, sold under the brand name Prograf among others, is an immunosuppressive drug. After an allogenic organ transplant, the risk of organ rejection is moderate; tacrolimus is used to lower the risk of organ rejection. Tacrolimus is also sold as a topical medication for treating T cell-mediated diseases, such as eczema and psoriasis. For example…
The analysis highlights History, Applications and Research as prominent areas in the source structure around Tacrolimus.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Tacrolimus shows recurring relationship patterns in the source. For example, Tacrolimus → Archived, Drug Administration, FDA, FDA Approves New Use, Food, July, Medicine Medical Subject Headings, MedlinePlus, MeSH, National Library, Real-World Evidence, September, Tacrolimus Injection, Tacrolimus Topical, Transplant Drug Based Another extracted example is Tacrolimus → Achieving, Across, African, Caucasian, CYP3A5, Genetic, However, In, NR1I2, PXR, SNP, Studies, The, There. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
drug also transplant rejection used liver topical risk use include kidney calcineurin macrolide molecule one enzyme cyp3a5 cancer name first
TTTA extracted 139 structured relationships around Tacrolimus. Examples in this analysis include Tacrolimus → 3D model (JSmol) → Interactive image and Tacrolimus → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Tacrolimus | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Tacrolimus | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Tacrolimus | ATC code | D11AH01 (WHO) L04AD02 (WHO) | 1.00 | infobox |
| Tacrolimus | Bioavailability | 24% (5–67%), less after eating food rich in fat | 1.00 | infobox |
| Tacrolimus | CAS Number | 104987-11-3 Y | 1.00 | infobox |
| Tacrolimus | ChEBI | CHEBI:61049 | 1.00 | infobox |
| Tacrolimus | ChEMBL | ChEMBL269732 Y | 1.00 | infobox |
| Tacrolimus | ChemSpider | 393220 Y | 1.00 | infobox |
| Tacrolimus | CompTox Dashboard (EPA) | DTXSID5046354 | 1.00 | infobox |
| Tacrolimus | DrugBank | DB00864 Y | 1.00 | infobox |
| Tacrolimus | ECHA InfoCard | 100.155.367 | 1.00 | infobox |
| Tacrolimus | Elimination half-life | 11.3 h for transplant patients (range 3.5–40.6 h) | 1.00 | infobox |
| Tacrolimus | Excretion | Mostly fecal | 1.00 | infobox |
| Tacrolimus | Formula | C44H69NO12 | 1.00 | infobox |
| Tacrolimus | KEGG | D08556 Y | 1.00 | infobox |
| Tacrolimus | KEGG | D00107 Y | 1.00 | infobox |
| Tacrolimus | Legal status | CA: ℞-only | 1.00 | infobox |
| Tacrolimus | Legal status | US: ℞-only | 1.00 | infobox |
| Tacrolimus | Legal status | EU: Rx-only | 1.00 | infobox |
| Tacrolimus | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Tacrolimus | License data | US DailyMed: Tacrolimus | 1.00 | infobox |
| Tacrolimus | MedlinePlus | a601117 | 1.00 | infobox |
| Tacrolimus | Metabolism | Liver CYP3A4, CYP3A5 | 1.00 | infobox |
| Tacrolimus | Molar mass | 804.031 g·mol−1 | 1.00 | infobox |
| Tacrolimus | Other names | FK-506, fujimycin | 1.00 | infobox |
| Tacrolimus | PDB ligand | FK5 (PDBe, RCSB PDB) | 1.00 | infobox |
| Tacrolimus | Pregnancy category | AU: C | 1.00 | infobox |
| Tacrolimus | Protein binding | ≥98.8% | 1.00 | infobox |
| Tacrolimus | PubChem CID | 445643 | 1.00 | infobox |
| Tacrolimus | Routes of administration | Topical, by mouth, intravenous | 1.00 | infobox |
The concept neighborhoods around Tacrolimus bring nearby vocabulary together. In this analysis, examples include Concentrations, Topical and Use. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Tacrolimus, one of the stronger structural bridges in this analysis connects Tacrolimus with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Tacrolimus to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Applications & Research, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Tacrolimus · EN edition · Analysis: TopicsToTalkAbout